The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders

Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders

December 1, 2013 • By Simon M. Helfgott, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases
  • 2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis
  • Pattern Recognition Key to Fibrosing Lung Disease Diagnosis
Explore This Issue
December 2013
Also By This Author
  • Inflammatory Origin of Fever Is Key to Diagnosis
Skin Deep
“Still Glows” (glüht nach) by Paul Klee.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Helfgott
Dr. Helfgott

In its more aggravated forms, diffuse scleroderma is one of the most terrible of all human ills. Like Tithonus, to wither slowly, and like him to be beaten down and marred and wasted until one is literally a mummy, encased in an ever shrinking, slowly contracting skin of steel, is a fate not pictured in any tragedy, ancient or modern.

—Sir William Osler

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The pain passes but the beauty remains.

—Pierre-Auguste Renoir

The great 20th century Swiss painter Paul Klee might have benefitted from the care of a rheumatologist. A complex and enigmatic artist, he left behind a staggering 10,000 pieces of art at the time of his death in 1940. He constantly experimented with new techniques and styles, drawing squares, triangles, or domes using sun-splashed colors. He believed that the role of abstract art was to create the reality behind visible things.1

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In 1933, dark clouds were amassing over Germany. Klee refused to declare his loyalty to the newly installed Nazi regime and was dismissed from his job. The persecution intensified, and his works were removed from private and public German collections. Seventeen of his paintings, along with others produced by Pablo Picasso, Edvard Munch, and Marc Chagall, were included in Joseph Goebbels’ infamous Entartete Kunst (Degenerate Art) show. The exhibition, which was viewed by millions of Germans, was designed to ridicule and denigrate creative art that did not uphold “correct” National Socialist virtues. Most of the exhibit was burned in the courtyard of a Berlin fire station, and some pieces were auctioned off to the highest bidders.2

It was around this time that Klee, who had fled to Bern, Switzerland, became ill. He developed severe fatigue and a skin rash that his physicians speculated was due to measles. However, this would have been a rather unlikely diagnosis in a 56-year-old male. An alternative interpretation has been offered by an expert on Klee, our colleague, John Varga, MD, the John and Nancy Hughes Distinguished Professor in rheumatology at Northwestern University in Chicago. He hypothesized that Klee’s facial rash was caused by an eruption of telangiectasia, the earliest sign of what became a full-blown case of scleroderma.2 Within months, this avid hiker experienced exertional dyspnea and worsening dysphagia that restricted his diet to liquids. In his letters, he described having arthritic pain in his hands, making it difficult to hold a paintbrush. As Klee’s health declined, his friends, Pablo Picasso and Georges Braque, came to pay homage. Despite being given the diagnosis of scleroderma, Paul Klee was not done painting.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Rheuminations Tagged With: fibrosis, Pathogenesis, Raynaud’s phenomenon, Scleroderma, Systemic sclerosisIssue: December 2013

You Might Also Like:
  • Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases
  • 2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis
  • Pattern Recognition Key to Fibrosing Lung Disease Diagnosis
  • Rheuminations: New Rules for Rheumatologists

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.